These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9881821)

  • 1. Erythrocyte as a potential model for study of lifelong somatic mutations.
    Gerashchenko BI
    Med Hypotheses; 1998 Aug; 51(2):145-6. PubMed ID: 9881821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human in vivo somatic mutation measured at two loci: individuals with stably elevated background erythrocyte glycophorin A (gpa) variant frequencies exhibit normal T-lymphocyte hprt mutant frequencies.
    Bigbee WL; Fuscoe JC; Grant SG; Jones IM; Gorvad AE; Harrington-Brock K; Strout CL; Thomas CB; Moore MM
    Mutat Res; 1998 Feb; 397(2):119-36. PubMed ID: 9541637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The assessment of in vivo somatic mutations in survivors of childhood malignancy.
    Hewitt M; Mott MG
    Br J Cancer; 1992 Jul; 66(1):143-7. PubMed ID: 1637665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology, and human risk assessment.
    Hussain SP; Hollstein MH; Harris CC
    Ann N Y Acad Sci; 2000; 919():79-85. PubMed ID: 11083100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The assessment of group heterogeneity for cancer morbidity and mortality of the population in areas with high technogenic loading].
    Kochetkov AP; Isakevich VV; Garipov AB; Simonova NI; Shepilov MA
    Med Tr Prom Ekol; 1997; (8):39-42. PubMed ID: 9377055
    [No Abstract]   [Full Text] [Related]  

  • 6. Somatic cell mutations in cancer epidemiology.
    Albertini RJ; Hayes RB
    IARC Sci Publ; 1997; (142):159-84. PubMed ID: 9354918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A site specific model and analysis of the neutral somatic mutation rate in whole-genome cancer data.
    Bertl J; Guo Q; Juul M; Besenbacher S; Nielsen MM; Hornshøj H; Pedersen JS; Hobolth A
    BMC Bioinformatics; 2018 Apr; 19(1):147. PubMed ID: 29673314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic-cell mutations as a possible predictor of cancer risk.
    Akiyama M; Umeki S; Kusunoki Y; Kyoizumi S; Nakamura N; Mori T; Ishikawa Y; Yamakido M; Ohama K; Kodama T
    Health Phys; 1995 May; 68(5):643-9. PubMed ID: 7730060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Origin of mutation in neoplasia.
    Morris SA
    Med Hypotheses; 1988 Nov; 27(3):209-14. PubMed ID: 3211017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Environmental factors as regulators and effectors of multistep carcinogenesis.
    Minamoto T; Mai M; Ronai Z
    Carcinogenesis; 1999 Apr; 20(4):519-27. PubMed ID: 10223177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations, evolution and the central role of a self-defined fitness function in the initiation and progression of cancer.
    Gatenby RA; Brown J
    Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):162-166. PubMed ID: 28341421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetic monitoring of human populations at risk in Egypt: role of cytogenetic data in cancer risk assessment.
    Anwar WA
    Environ Health Perspect; 1991 Dec; 96():91-5. PubMed ID: 1820285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human somatic mutation assays as biomarkers of carcinogenesis.
    Compton PJ; Hooper K; Smith MT
    Environ Health Perspect; 1991 Aug; 94():135-41. PubMed ID: 1954924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related somatic mutations in the cancer genome.
    Milholland B; Auton A; Suh Y; Vijg J
    Oncotarget; 2015 Sep; 6(28):24627-35. PubMed ID: 26384365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic mutation in cancer and normal cells.
    Martincorena I; Campbell PJ
    Science; 2015 Sep; 349(6255):1483-9. PubMed ID: 26404825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular oncogenes, mutations and cancer.
    Spandidos DA
    Anticancer Res; 1983; 3(2):121-5. PubMed ID: 6847130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomonitoring for genotoxic effects has a low sensitivity in terms of cancer risks associated with lifelong exposures starting in utero.
    van Larebeke N
    Biomed Pharmacother; 2007 Dec; 61(10):679-81. PubMed ID: 17988827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond bad luck: induced mutations and hallmarks of cancer.
    Kelly-Irving M; Delpierre C; Vineis P
    Lancet Oncol; 2017 Aug; 18(8):999-1000. PubMed ID: 28759371
    [No Abstract]   [Full Text] [Related]  

  • 19. Monitoring humans for somatic mutation in the endogenous PIG-a gene using red blood cells.
    Dobrovolsky VN; Elespuru RK; Bigger CA; Robison TW; Heflich RH
    Environ Mol Mutagen; 2011 Dec; 52(9):784-94. PubMed ID: 21826740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic cell gene mutations in humans: biomarkers for genotoxicity.
    Albertini RJ; Nicklas JA; O'Neill JP
    Environ Health Perspect; 1993 Oct; 101 Suppl 3(Suppl 3):193-201. PubMed ID: 8143616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.